QIAGEN N.V.

For the period ended Dec 31, 2024. Filed Mar 31, 2025.

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2024 · Filed Mar 31, 2025

QGEN$50.33-1.0%Stored close · as of Nov 6, 2026

Contents

Item	Form 20-F Caption	Section	Location in this Document	Page
Part I
Item 1. · Identity of Directors, Senior Management and Advisers · Not applicable.
Item 2. · Offer Statistics and Expected Timetable · Not applicable.
Item 3. · Key Information
A. [Reserved]
B. Capitalization and Indebtedness · Not applicable.
C. Reasons for the Offer and Use of Proceeds · Not applicable.
	D. Risk Factors	MR	Risk Factors	38
Item 4.	Information on the Company
	A. History and Development of the Company	MR	Business and Operating Environment	10
	B. Business Overview	MR	Business and Operating Environment	10
		MR	Conflict Minerals	21
		APP	Government Regulations	187
	C. Organizational Structure	MR	Company Overview	10
	D. Property, Plants and Equipment	MR	Description of Property	21
Item 4A.	Unresolved Staff Comments		Not applicable.
Item 5.	Operating and Financial Review and Prospects
	A. Operating Results	MR	Operating Results	24
	B. Liquidity and Capital Resources	MR	Liquidity and Capital Resources	29
	C. Research and Development, Patents and Licenses, etc.	MR	Research and Development	18
		MR	Intellectual Property, Proprietary Rights and Licenses	20
		MR	Research and Development	27

Appendices
QIAGEN N.V. \| Financial Report 2024	Overview	Management Report	Corporate Governance	Financial Statements	Appendices	Page 204

Item	Form 20-F Caption	Section	Location in this Document	Page
Item 5.	D. Trend Information	MR	Operating Results	24
	E. Critical Accounting Estimates	MR	Critical Accounting Estimates	34
Item 6.	Directors, Senior Management and Employees
	A. Directors and Senior Management	CG	Corporate Governance	52
	B. Compensation	CG	Compensation of Managing Board Members and Supervisory Directors	76
	C. Board Practices	CG	Supervisory Board	57
	D. Employees	MR	Employees	22
	E. Share Ownership	CG	Share Ownership	80
F. Disclosure of a registrant’s action to recover erroneously awarded compensation · Not applicable.
Item 7.	Major Shareholders and Related Party Transactions
	A. Major Shareholders	CG	Major Shareholders	66
	B. Related Party Transactions	FS	Note 24. Related Party Transactions	166
C. Interests of Experts and Counsel · Not applicable.
Item 8.	Financial Information
	A. Consolidated Statements and Other Financial Information	FS	Consolidated Financial Statements	81
		MR	Policy on Dividend Distribution	34
		MR	Legal Proceedings	29
	B. Significant Changes	APP	Disclosure pursuant to Section 219 of the Iran Threat Reduction & Syria Human Rights Act (ITRA)	201
Item 9.	The Offer and Listing
	A. Offer and Listing Details	QS	QIAGEN Shares	5
B. Plan of Distribution · Not applicable.
	C. Markets	QS	QIAGEN Shares	5
D. Selling Shareholders · Not applicable.
E. Dilution · Not applicable.
F. Expenses of the Issue · Not applicable.

Appendices
QIAGEN N.V. \| Financial Report 2024	Overview	Management Report	Corporate Governance	Financial Statements	Appendices	Page 205

Item	Form 20-F Caption	Section	Location in this Document	Page
Item 10. · Additional Information
A. Share Capital · Not applicable.
	B. Memorandum and Articles of Association	APP	Memorandum and Articles of Association	168
C. Material Contracts · Not applicable.
	D. Exchange Controls	APP	Exchange Controls	200
	E. Taxation	APP	Taxation	181
F. Dividends and Paying Agents · Not applicable.
G. Statement by Experts · Not applicable.
	H. Documents on Display	APP	Documents on Display	200
I. Subsidiary Information · Not applicable.
Item 11.	Quantitative and Qualitative Disclosures about Market Risk	MR	Quantitative and Qualitative Disclosures about Market Risk	32
Item 12.	Description of Securities Other than Equity Securities		Not applicable.
Part II
Item 13.	Defaults, Dividend Arrearages and Delinquencies		Not applicable.
Item 14.	Material Modifications to the Rights of Security Holders and Use of Proceeds		Not applicable.
Item 15.	Controls and Procedures	APP	Controls and Procedures	200
Item 16.	[Reserved]
Item 16A.	Audit Committee Financial Expert	CG	Audit Committee	58
Item 16B.	Code of Ethics	CG	Corporate Code of Conduct and Ethics and Whistleblower Policy	71
Item 16C.	Principal Accountant Fees and Services	APP	Principal Accountant Fees and Services	180
Item 16D.	Exemptions from the Listing Standards for Audit Committees		Not applicable.
Item 16E.	Purchases of Equity Securities by the Issuer and Affiliated Purchasers		Not applicable.
Item 16F.	Change in Registrant’s Certifying Accountant	APP	Change in Registrant's Certifying Accountant	180

Appendices
QIAGEN N.V. \| Financial Report 2024	Overview	Management Report	Corporate Governance	Financial Statements	Appendices	Page 206

Item	Form 20-F Caption	Section	Location in this Document	Page
Item 16G.	Corporate Governance	CG	NYSE Exemptions	75
Item 16H.	Mine Safety Disclosure		Not applicable.
Item 16I.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections		Not applicable.
Item 16J.	Insider Trading Policies	CG	Insider Trading Policy	72
Item 16K.	Cybersecurity	CG	Cyber Security	70
Part III
Item 17.	Financial Statements		See Item 18.
Item 18.	Financial Statements	FS	Consolidated Financial Statements	81
Item 19.	Exhibits	EX	Exhibit Index	207
This document includes references to certain information contained on QIAGEN's website. The information contained on QIAGEN's website is not incorporated by reference and does not form part of this document.
Section abbreviations:
APP	Appendices
CG	Corporate Governance
EX	Exhibit Index
FS	Financial Statements
MR	Management Report
QS	QIAGEN Shares

Exhibit Index
QIAGEN N.V. \| Financial Report 2024	Overview	Management Report	Corporate Governance	Financial Statements	Appendices	Page 207

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.